Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid Leukemia
Global mass spectrometry (MS)-based proteomic and phosphoproteomic studies of acute myeloid leukemia (AML) biomarkers represent a powerful strategy to identify and confirm proteins and their phosphorylated modifications that could be applied in diagnosis and prognosis, as a support for individual tr...
Main Authors: | Maria Hernandez-Valladares, Elise Aasebø, Frode Selheim, Frode S. Berven, Øystein Bruserud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-08-01
|
Series: | Proteomes |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-7382/4/3/24 |
Similar Items
-
The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles
by: Elise Aasebø, et al.
Published: (2020-06-01) -
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5
by: Frode Selheim, et al.
Published: (2023-12-01) -
Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia
by: Elise Aasebø, et al.
Published: (2020-03-01) -
The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives
by: Maria Hernandez-Valladares, et al.
Published: (2020-09-01) -
Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators
by: Elise Aasebø, et al.
Published: (2018-12-01)